Find trials
Consejos para buscar

New-onset Atrial Fibrillation and Flutter Following Cardiac Surgery

Overview

Información sobre este estudio

The aims of this investigation are:

To assess the predictive value (and accuracy) of clinical and physiologic preoperative variables in identifying patients at risk for the development of new-onset atrial arrhythmia after cardiac surgery.

To assess the feasibility of a physiological risk model based on clinical and echocardiographic indexes to predict post-operative AF.

To assess the role of prophylactic agents in the prevention of new-onset postoperative POAF

To assess the economic impact of new-onset postoperative AF:

  • Length of hospital stay (will be measured as fractions of days)

  • Hospital cost (will be measured in standardized dollars)

  • Resource utilization (will be measured by resource-based relative-value units)

To assess the outcome of patients who develop early atrial fibrillation following cardiac surgery:

  • To assess whether first time new-onset POAF predicts long-term AF.

  • Examine the predictive value of potential preoperative variables in identifying patients at risk of developing

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion criteria:

  • This will be historical cohort study of all patients above the age of 18 with preoperative sinus rhythm who underwent cardiac surgery, including Transcatheter Aortic Valve Replacement (TAVR) at the Mayo Clinic between 1990 and 2013.

    Exclusion criteria:

    • Patients who have denied research access to their medical records will not be included in the study (Minnesota state law [Minn Stat 144.335 subd. 3a (d)]).Since the study involves minimal risk to the patients, we will request waiver of informed consent and use HIPAA authorization.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Rowlens Melduni, M.D., M.P.H.

Cerrado para la inscripción

Contact information:

Rowlens Melduni M.D., M.P.H.

(507)284-9601

Melduni.Rowlens@mayo.edu

More information

Publicaciones

Publications are currently not available

Otros temas en investigación

.
CLS-20315008

Mayo Clinic Footer